Monoglyceride lipase: Structure and inhibitors.

Area of Science:

• Biochemistry
• Enzymology
• Pharmacology

Background:

• Monoglyceride lipase (MGL) hydrolyzes 2-arachidonoyl-sn-glycerol (2-AG), a crucial endocannabinoid.
• MGL is implicated in physiological and pathological processes including pain, inflammation, neuroprotection, and cancer.

Purpose of the Study:

• To review current knowledge on MGL structure and function.
• To discuss various classes of MGL inhibitors and their mechanisms.
• To highlight unresolved questions regarding MGL conformational dynamics and cysteine residue roles.

Main Methods:

• Analysis of available MGL crystal structures.
• Review of literature on MGL inhibitors (reversible, carbamoylating, cysteine-interacting).
• Discussion of enzyme mechanisms and structure-activity relationships.

Main Results:

• Existing crystal structures offer insights into MGL inhibition.
• Multiple inhibitor classes targeting MGL have been developed.
• The roles of MGL conformational equilibria and cysteine residues require further investigation.

Conclusions:

• Understanding MGL structure and dynamics is vital for drug development.
• Targeting MGL offers therapeutic potential for various diseases.
• Further research is needed to elucidate MGL regulation by cysteine residues.